KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) EBITDA Margin (2016 - 2026)

Bausch Health Companies' EBITDA Margin history spans 18 years, with the latest figure at 37.64% for Q1 2026.

  • On a quarterly basis, EBITDA Margin fell 4986.0% to 37.64% in Q1 2026 year-over-year; TTM through Mar 2026 was 5.57%, a 1026.0% decrease, with the full-year FY2025 number at 17.66%, up 160.0% from a year prior.
  • EBITDA Margin hit 37.64% in Q1 2026 for Bausch Health Companies, down from 16.95% in the prior quarter.
  • Over the last five years, EBITDA Margin for BHC hit a ceiling of 23.09% in Q3 2025 and a floor of 37.64% in Q1 2026.
  • Historically, EBITDA Margin has averaged 9.63% across 5 years, with a median of 13.05% in 2024.
  • Biggest five-year swings in EBITDA Margin: soared 2579bps in 2023 and later plummeted -4986bps in 2026.
  • Tracing BHC's EBITDA Margin over 5 years: stood at 10.76% in 2022, then surged by 240bps to 15.03% in 2023, then skyrocketed by 45bps to 21.81% in 2024, then dropped by -22bps to 16.95% in 2025, then plummeted by -322bps to 37.64% in 2026.
  • Business Quant data shows EBITDA Margin for BHC at 37.64% in Q1 2026, 16.95% in Q4 2025, and 23.09% in Q3 2025.